Bios Health Group Unveils Bios Innovation Circle™

Bios Health Group Unveils Bios Innovation Circle™ Groundbreaking venture studio and strategic hub empowers members with comprehensive arsenal of benefits to dominate the life sciences arena

ResultsCX Named ‘Major Player’ in NelsonHall’s NEAT Vendor Evaluation for CX Services Transformation

Emmes Endpoints Solutions Submits Duchenne Video Assessment Qualification Plan to FDA

Bespak confirms completion of inhaled and nasal drug delivery business separation from Recipharm to focus on the transition to low GWP pMDIs

Spin-out unites three sites to create a leading global CDMO as further significant investments announced at Holmes Chapel site

Tome Biosciences Announces US Patent Issued for Integrase-Mediated Programmable Genomic Integration

Tome Biosciences, Inc., the programmable genomic integration (PGI) company, today announces the issuance of US Patent 11,952,571 for “Systems, Methods, and Compositions for Site-Specific Genetic Engineering Using Programmable Addition via Site-Specific Targeting Elements (PASTE)” by the US Patent and Trademark Office. This patent further protects Tome’s foundational PGI technology, integrase-mediated PGI (I-PGI), describes a system capable of performing I-PGI in a mammalian cell, and is exclusively licensed to Tome from MIT.

Model Medicines Unveils Groundbreaking AI Drug Discovery Advances in New Chemistry and New Biology with Two New Preprint Papers

Model Medicines has announced the upcoming release of two groundbreaking preprint papers on bioRxiv, detailing significant advances in antiviral and oncology drug discovery using their GALILEO AI platform. The first preprint reveals the discovery of a novel broad-spectrum antiviral target and inhibitor, while the second introduces ChemPrint, a deep learning model that achieved a remarkable 45.5% hit rate in identifying novel inhibitors of challenging oncology targets. These findings build upon Model Medicines' recent successes and underscore the transformative potential of their AI platform in revolutionizing drug discovery.

CG LIFE ACQUIRES TOOLHOUSE, SIGNIFICANTLY EXPANDING TECHNOLOGY-ENABLED OMNICHANNEL CAPABILITIES

CG Life is acquiring Toolhouse, doubling agency size and strengthening expertise in creating impactful digital experiences connecting with clinical and patient audiences.

Phenomix Sciences Launches Three-in-One Obesity Phenotyping Test, Adding Emotional Hunger and Personalized Lifestyle Guidance

New MyPhenome test delivers patients and providers with the most comprehensive and actionable insights yet into their obesity type(s).

Andaman7 Launches AI Supercharged Personal Health Record v5

Andaman7 Launches AI Supercharged Personal Health Record v5 New advanced AI Simplification, Summarization and Translation features empower patients and improve communication with healthcare providers and researchers.

Universal Brain Expands Executive Team to Accelerate Precision Psychiatry

Universal Brain Expands Executive Team to Accelerate Precision Psychiatry

AONL and Laudio Release New Report Measuring the Impact of Nurse Managers on Health System Performance

Peerbridge Health’s Remote Device for Early Detection of Heart Failure Achieves 95.7% Success Rate in Trial

Peerbridge Health’s Remote Device for Early Detection of Heart Failure Achieves 95.7% Success Rate in Trial

Lindus Health Unveils Versatile “All-in-One Respiratory CRO” Offering Tailored to Respiratory Clinical Trials

Lindus Health Unveils Versatile “All-in-One Respiratory CRO” Offering Tailored to Respiratory Clinical Trials

Scope of Industry Risk-Based Quality Management (RBQM) Adoption Revealed

Scope of Industry Risk-Based Quality Management (RBQM) Adoption Revealed CluePoints, the Tufts Center for the Study of Drug Development and PwC publish Comprehensive Assessment of RBQM Adoption in Clinical Trials.

New study explores how Switzerland can maintain its leading position in life science innovation

The RSA Group, a leading life sciences executive search firm, has published the latest of its Talent Equity Reports: “Sustaining a winning position” – an analysis of how Switzerland can continue to lead the life sciences sector in a shifting global market.

Integrated DNA Technologies Unveils New Custom Vector Onboarding Tool to Optimize Gene Synthesis

Global genomics solutions provider Integrated DNA Technologies (IDT) is expanding its gene synthesis offerings with a new custom vector onboarding tool.

North Carolina Takes the Lead in PFAS Research with Collaboratory's $3 Million Investment to Expand the State's Research Capacity

One2Treat launches groundbreaking treatment-decision approach to clinical research and market access analysis

One2Treat launches groundbreaking treatment-decision approach to clinical research and market access analysis One2Treat reflects patient priorities in a single comprehensive treatment evaluation, reducing trial sample size and accelerating patient access to new treatments

Illumina Throws Weight Behind National Initiative to Assess Potential of Exhaustive Genomic Profiling in Advanced Cancer Real-World Scenario Across Belgium

SIRIO launches personalised women’s health platform at Vitafoods Europe

New ready-to-launch formulation range features premium branded ingredients, and targets issues as diverse as PMS, fertility, prenatal & postnatal care and menopause wellbeing.